Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study

Completed

• Conditions: Ischemic Stroke

• Registration Number: NCT01843361
• Lead Sponsor: Ruhr University of Bochum

Brief Summary

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2013-04
• Study First Submitted: 2013-04-26
• Study First Submitted QC: 2013-04-26
• Last Update Submitted: 2013-04-26
• Study First Posted: 2013-04-30
• Last Update Posted: 2013-04-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 159

Inclusion Criteria

• acute ischemic stroke
• admittance to stroke unit
• clopidogrel medication

Exclusion Criteria

• no consent
• prior bleeding disorders
• severe liver disorders
• current gastrointestinal disorders
• congestive heart failure
• life-threatening malignancies

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Result of platelet function test	one day	Aggregometry result of antiplatelet therapy

Trial Locations

Locations (1)

Department of Neurology, Ruhr University Bochum; 🇩🇪 Bochum, Germany